Imed Infinity Medical LP (XTAE:IMED) EPS without NRI: ₪ (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:IMED Imed Infinity Medical LP XTAE:IMED
18 GF Score
Price ₪0.89
! 2 Warning Signs
View Full Analysis

What is Imed Infinity Medical LP EPS without NRI?

Imed Infinity Medical LP XTAE:IMED 18 EPS without NRI is ₪ as of . 20. GuruFocus rates XTAE:IMED with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Imed Infinity Medical LP ranks worse than 197238.46% on this metric.

Imed Infinity Medical LP's earnings per share without non-recurring items for the six months ended in . 20 was ₪0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Imed Infinity Medical LP's EPS without NRI or its related term are showing as below:

XTAE:IMED's 3-Year EPS without NRI Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Imed Infinity Medical LP's EPS (Diluted) for the six months ended in . 20 was ₪0.00.

Imed Infinity Medical LP's EPS (Basic) for the six months ended in . 20 was ₪0.00.


Imed Infinity Medical LP  (XTAE:IMED) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Imed Infinity Medical LP EPS without NRI Related Terms


Imed Infinity Medical LP EPS without NRI Historical Data

* Premium members only.

The historical data trend for Imed Infinity Medical LP's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imed Infinity Medical LP EPS without NRI Chart

Imed Infinity Medical LP Annual Data
Trend
EPS without NRI

Imed Infinity Medical LP Semi-Annual Data
EPS without NRI

XTAE:IMED vs VEEV, BTSG, HQY: EPS without NRI Comparison

For the Health Information Services subindustry, Imed Infinity Medical LP's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imed Infinity Medical LP PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Imed Infinity Medical LP's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Imed Infinity Medical LP's PE Ratio without NRI falls into.


XTAE:IMED
18GF Score
Imed Infinity Medical LP XTAE:IMED
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imed Infinity Medical LP EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS without NRI for the trailing twelve months (TTM) ended in . 20 was ₪

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of ₪ mean?
Imed Infinity Medical LP (XTAE:IMED) has a EPS without NRI of ₪ as of . 20. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Imed Infinity Medical LP and its competitors. According to the industry distribution chart, Imed Infinity Medical LP ranks #999999 out of 507 companies in the Healthcare Providers & Services industry.
Is Imed Infinity Medical LP's EPS without NRI too high?
Imed Infinity Medical LP's current EPS without NRI is ₪. Based on the distribution chart, Imed Infinity Medical LP ranks #999999 out of 507 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Imed Infinity Medical LP has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Imed Infinity Medical LP's EPS without NRI compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imed Infinity Medical LP ranks #999999 out of 507 companies for EPS without NRI. This places Imed Infinity Medical LP in the lower half of its industry. The industry median EPS without NRI is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.00, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Imed Infinity Medical LP and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imed Infinity Medical LP's current EPS without NRI is ₪. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imed Infinity Medical LP stock overvalued right now?
Imed Infinity Medical LP (XTAE:IMED) has a current EPS without NRI of ₪. The current EPS without NRI is ₪. Imed Infinity Medical LP's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Imed Infinity Medical LP (XTAE:IMED), the current EPS without NRI is ₪ as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imed Infinity Medical LP Business Description

Address Azrieli Center, Menachem Begin 132, Triangle Tower 42th Floor, Tel Aviv, ISR, 6701101
Imed Infinity Medical LP is engaged in the business of investing in digital health businesses.
18GF Score

Get the complete analysis for XTAE:IMED

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.89
Price